Cytomegalovirus

24 registered clinical trials studyying Cytomegalovirus — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Recruiting	Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) NCT06958796	Camille N. Kotton, MD	Phase 4
Recruiting	Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hemato NCT05664126	St. Jude Children's Research Hospital	Phase 2
Active Not Recruiting	A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 NCT05575492	ModernaTX, Inc.	Phase 1 / Phase 2
Completed	A Study of Modified mRNA Vaccines in Healthy Adults NCT05397223	ModernaTX, Inc.	Phase 1
Terminated	A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficien NCT04840199	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Recruiting	Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT NCT03665675	Sumithira Vasu	EARLY_Phase 1
Terminated	Clinical Performance Evaluation of DxN CMV Assay NCT03127787	Beckman Coulter, Inc.	—
Completed	Review of Human Herpes Viruses in Burns NCT02452229	The University of Texas Medical Branch, Galveston	—
Completed	Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney NCT01895049	Helio Tedesco Silva Junior	Phase 4
Completed	Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients NCT02083042	Lophius Biosciences GmbH	—
Completed	Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV NCT01646645	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) i NCT01248598	Rambam Health Care Campus	—
Completed	Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age NCT01195571	CMV Research Foundation	Phase 1
Completed	The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred fo NCT01162330	Newcastle-upon-Tyne Hospitals NHS Trust	—
Completed	Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussi NCT01160081	GlaxoSmithKline	—
Completed	Detection of Human Cytomegalovirus in the Saliva NCT00815802	University Hospital, Limoges	—
Completed	Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patient NCT00467532	University of North Carolina, Chapel Hill	—
Completed	CMV Disease and IRIS in HIV-1 Infected Persons NCT00456664	Kaohsiung Medical University Chung-Ho Memorial Hospital	—
Completed	Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients NCT01008540	University Hospital, Limoges	N/A
Completed	Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantat NCT00330018	Hadassah Medical Organization	Phase 3
Completed	Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy NCT00366717	Mackay Memorial Hospital	—
Suspended	Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms NCT00668798	Johann Wolfgang Goethe University Hospital	—
Completed	The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With NCT00214240	University of Wisconsin, Madison	N/A